Brimonidine (Brimonidine Tartrate Ophthalmic) - Indications and Dosage

INDICATIONS AND USAGE

Brimonidine tartrate ophthalmic solution is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The IOP lowering efficacy of brimonidine tartrate ophthalmic solution diminishes over time in some patients. This loss of effect appears with a variable time of onset in each patient and should be closely monitored.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of brimonidine tartrate ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart.

Brimonidine Tartrate Ophthalmic Solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

HOW SUPPLIED

Brimonidine Tartrate Ophthalmic Solution 0.2% is available as a greenish-yellow clear solution supplied in sterile, white opaque plastic dropper bottles as follows: 5 mL, 10 mL and 15 mL.

PHARMACIST: Store and dispense in the original container at 20°C - 25°C (68°F - 77°F) [See USP Controlled Room Temperature].

Manufactured for: 0172

IVAX Pharmaceuticals, Inc. 06/04

Miami, FL 33137 B1

by: Ivax Pharmaceuticals UK

Runcorn, England WA7 3FA

Made In England